Europe Rheumatology Drugs Market was valued at USD 12 Billion in 2022 and is projected to reach USD 18 Billion by 2030, growing at a CAGR of 6.1% from 2024 to 2030.
The European rheumatology drugs market is experiencing significant growth, driven by the increasing prevalence of rheumatic diseases and advancements in pharmaceutical research. As of 2024, the market is projected to reach a revenue of approximately US$4.93 billion, with expectations to grow at a Compound Annual Growth Rate (CAGR) of 0.60% from 2024 to 2029, culminating in a market volume of US$5.08 billion by 2029. This growth is primarily fueled by the rising incidence of conditions such as rheumatoid arthritis and osteoarthritis, coupled with an aging population that is more susceptible to these ailments. citeturn0search3
In terms of market segmentation, the European rheumatology drugs market is categorized based on disease type, therapeutic molecule, and sales channel. The primary disease categories include osteoarthritis, rheumatoid arthritis, gout, lupus, and others. Therapeutic molecules are divided into pharmaceuticals and biopharmaceuticals, with the latter encompassing biologics and biosimilars. Sales channels are classified as prescription-based and over-the-counter (OTC) options. Germany leads the market, attributed to its robust pharmaceutical industry and high demand for innovative treatments. citeturn0search0
Pharmaceutical companies are increasingly focusing on the development of biologic drugs, which offer superior efficacy compared to traditional disease-modifying antirheumatic drugs (DMARDs). However, the high cost of biologics has spurred the growth of biosimilars—cost-effective alternatives that are gaining traction in the European market. The competitive landscape features key players such as AbbVie, Pfizer, GlaxoSmithKline, Eli Lilly, and Amgen, all of which are actively involved in research and development to introduce novel therapies. citeturn0search2
The demand for rheumatology drugs in Europe is also influenced by the accessibility of treatments and the availability of healthcare insurance. The increasing awareness about autoimmune diseases and the benefits of early diagnosis and treatment have led to a higher adoption rate of these medications. Nonetheless, challenges such as pricing pressures and the emergence of biosimilars pose potential threats to market revenues. citeturn0search3
Overall, the European rheumatology drugs market is poised for steady growth, driven by continuous advancements in drug development and a heightened focus on addressing the needs of patients with rheumatic diseases.
Get an In-Depth Research Analysis of the Europe Rheumatology Drugs Market Size And Forecast [2025-2032]
Takeda Pharmaceutical
Sanofi
Genentech
Novartis
Janssen Biotech
Amgen
AbbVie
Pfizer
Bristol-Myers Squibb Company
Merck & Co.
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe Rheumatology Drugs Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe Rheumatology Drugs Market
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
Biologics
Corticosteroids
Rheumatoid Arthritis
Osteoarthritis
Psoriatic Arthritis
Lupus
Gout
Ankylosing Spondylitis
Other Rheumatic Diseases
Oral
Injectable
Topical
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Biologics
Non-Biologic DMARDs
NSAIDs
Corticosteroids
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Rheumatology Drugs Market Research Analysis
1. Introduction of the Europe Rheumatology Drugs Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe Rheumatology Drugs Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe Rheumatology Drugs Market, By Type
6. Europe Rheumatology Drugs Market, By Application
7. Europe Rheumatology Drugs Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Europe Rheumatology Drugs Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Europe Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/